01777nas a2200325   4500000000100000008004100001260000900042653001100051653002100062653002100083653001800104653002200122653002100144653001100165653002300176653001200199653002200211653003000233100001500263700001600278700001500294700001600309700002000325700001300345245018200358300001000540490000700550520088000557022001401437       1996                            d  c199610aAfrica10aDisabled Persons10aHealth Education10aHealth Policy10aHealth Priorities10aHealth Promotion10aHumans10aLeprostatic Agents10aleprosy10aSocial Adjustment10aWorld Health Organization1 aDiallo A M1 aGrauwin M Y1 aHirzel C B1 aLienhardt C1 aTiendrebéogo A1 aGroupe D00a[Organization of a program for the prevention of disabilities and physical rehabilitation at the center of a national program in the campaign against leprosy: practical advice].  a29-350 v103 a<p>Patients treated and cured on the bacteriological level by multidrug therapy may nevertheless present handicaps, such as deformities resulting from the disease, which have personal and social consequences. It is actually the handicap and disability from which most patients suffer and which concern populations. The number of persons suffering from such handicaps worldwide has been estimated at 4 million. Therefore, the main goal is to gradually integrate the activities of the prevention of disabilities and physical rehabilitation programme (PIRP) into the national leprosy control programme (PNL). The persons involved in the implementation of the programme outline the activities planned under the PIRP, detailed objectives, priorities, the means by which they will be implemented, the content of training programmes, assessment criteria and documents available.</p>  a0001-5938